Absci Investor Presentation Deck

THE PROBLEM - CURRENT NEED FOR GENERATIVE AI The drug discovery paradigm is ripe for disruption 5.5 YEARS FROM DISCOVERY TO IND OPTIMIZE FOR AFFINITY OPTIMIZE FOR TOXICITY ABSCI CORPORATION 2023 ALL RIGHTS RESERVED OPTIMIZE FOR DEVELOPABILITY SUBOPTIMAL CANDIDATE Long iterative process resulting in drug candidates with suboptimal attributes <5% SUCCESS RATE FROM DISCOVERY TO LAUNCH CHI 0 IID absci 4

View entire presentation